Switch to: Citations

Add references

You must login to add references.
  1. The Hippocratic Bargain and Health Information Technology.Mark A. Rothstein - 2010 - Journal of Law, Medicine and Ethics 38 (1):7-13.
    Since the fourth century, B.C.E., the Oath of Hippocrates has been the starting point in analyzing the obligations of physicians to protect the privacy and confidentiality interests of their patients. The pertinent provision of the Oath reads as follows: “What I may see or hear in the course of the treatment or even outside of the treatment in regard to the life of men, which on no account must be spread abroad, I will keep to myself, holding such things shameful (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Biobank/Genomic Research in Nigeria: Examining Relevant Privacy and Confidentiality Frameworks.Obiajulu Nnamuchi - 2015 - Journal of Law, Medicine and Ethics 43 (4):776-786.
    Health research raises profound concerns of an ethical and legal nature — concerns primarily centered on how to balance researchers’ quest for scientific discovery against societal interest in protecting individuals whose participation makes the discovery possible. Particularly in a country such as Nigeria, which, not too long ago, suffered major abuse of research subjects, deploying a robust ethicolegal regime capable of curbing excesses and protecting research participants whilst contemporaneously not frustrating scientific progress is not an easy task. This is even (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • INTRODUCTION: Harmonizing Privacy Laws to Enable International Biobank Research.Mark A. Rothstein & Bartha Maria Knoppers - 2015 - Journal of Law, Medicine and Ethics 43 (4):673-674.
    The Journal of Law, Medicine &Ethics, Volume 43, Issue 4, Page 673-674, Winter 2015.
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Regulating Research with Biospecimens under the Revised Common Rule.Holly Fernandez Lynch & Michelle N. Meyer - 2017 - Hastings Center Report 47 (3):3-4.
    Since 2011, the research community had waited with bated breath as regulators contemplated for the first time bringing secondary research with nonidentifiable biospecimens under the Common Rule and dramatically tightening the criteria for waiving consent to biospecimen research. After considerable pushback from both researchers and patients and amid rumors of intractable disagreement among Common Rule agencies, the Final Rule published on the last day of President Obama's administration left out these troubling changes, and there was a collective sigh of relief. (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Genomic Databases and Biobanks in Israel.Gil Siegal - 2015 - Journal of Law, Medicine and Ethics 43 (4):766-775.
    In addressing the creation and regulation of biobanks in different countries, a short descriptive introduction to the social and cultural backgrounds of each country is mandatory. The State of Israel is relatively young, and can be characterized as a multi-religious, multi-ethnic, multi-cultural society, somewhat similar to the American melting pot. The current population is 8.3 million, a sharp rise resulting from a 1.2 million influx of immigrants from the former Soviet Union in the 1990s. Seventyfive percent are Jewish, 20% Arabs, (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations